Strategic Growth Suvoda has merged with Greenphire, expanding its unified platform capabilities and potential cross-sell opportunities across RTSM, eCOA, eConsent, patient payments, and travel solutions to current and new sponsors seeking end-to-end trial tech.

Awards Lead Recent MedTech Breakthrough awards for patient app and patient relationship management position Suvoda as a recognized innovator in patient engagement, creating openings to target sponsors prioritizing patient-centric experiences.

Clinical Expertise Strong focus on oncology, CNS, and rare diseases indicates a specialization that can be leveraged to pursue trials with complex logistics and high regulatory requirements, appealing to sponsors with high-touch patient management needs.

Tech Stack Robust technology foundation including Databricks, Airflow, Salesforce, and enterprise platforms suggests readiness for scale and integration with sponsor ecosystems; a selling point for customers seeking modern, interoperable trial tech.

Financial Scale Revenue in the mid to high hundreds of millions with a recent $40M funding round signals mature operations and room for expansion in enterprise accounts, plus potential for larger multi-study deals across sponsors and CROs.